This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Michael Koerner, MD
Department of Neurology University of New Mexico School of Medicine Albuquerque, NM 87131

Arch Neurol. 1979;36(13):859.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Metrizamide is known to pass over the convexities¹ of the brain and to penetrate into the cortex.² Headache, nausea, vomiting, nuchal rigidity, EEG abnormalities, seizures, rarely hyperacusis, hallucinations, and agitation have been reported after metrizamide myelography.^3-5 I have observed another possibly related adverse reaction.

Report of a Case.—

Pain developed in the back and right leg of a 22-year-old man. The only finding was a sensory deficit in an L-5 distribution on the right. Otherwise, he was healthy, was taking no medication, and had no history of allergy.

An hour before performance of lumbar myelography, he received 75 mg of meperidine hydrochloride and 0.4 mg of atropine intramuscularly. The procedure was performed with 6.75 g of metrizamide diluted to 16 cc. A narrow dural sac and a herniated disk at L4-5 were found.

During the next several hours, a headache developed and the patient . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?